A Mixed-method Pilot Investigation of Paradoxical Intention for Insomnia.
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-90
SponsorÖrebro University, Sweden
About this trial
The investigators aim to test the preliminary efficacy as well as the acceptability and feasibility of paradoxical intention, which is a psychotherapeutic technique, for improving insomnia symptoms in adults. Previous research has tested this technique for insomnia and found overall positive results. However, during the last decades very few studies have examined paradoxical intention. Therefore the investigators wish to conduct a pilot study examining the effects in a modern context.
Eligibility criteria
Qualifiers
Undergoing three screening phases: a web-based questionnaire, a telephone interview with a structured assessment, and a 7-day sleep diary completion.
Screening resulting in diagnosis of insomnia, including co-morbid insomnia.
Participant should fulfill the following DSM-5 criteria. (1)Difficulty in sleep Initiation, maintenance, or early morning awakening. (2)Frequency and duration of at least three nights per week and has been present for at least three months.(3) Problems persist despite candidates having had adequate opportunity and circumstances for sleep. (4) The sleep disturbance causes significant distress or impairment in social, occupational, educational, academic, behavioral, or other important areas of functioning.
Age above 18 and Swedish resident and language proficient.
Disqualifiers
Severe depressive episode with suicidal intentions or actions
Current or past diagnosis of psychotic or bipolar disorders
Current substance use disorder
Recent changes in psychopharmacotherapy (within the last three months) or use of "as-needed" hypnotic medications during the trial.
Trial design
Treatments tested in this trial
- Paradoxical Intention
Treatment groups
40 Participants
are divided into 1 treatment groupSponsors and collaborators
Örebro University, Sweden
Lead sponsor
Karolinska Institutet
Collaborator
Source ClinicalTrials.gov